Back to Search
Start Over
IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
- Source :
-
Atherosclerosis [Atherosclerosis] 2015 May; Vol. 240 (1), pp. 161-2. Date of Electronic Publication: 2015 Mar 10. - Publication Year :
- 2015
- Subjects :
- Anticholesteremic Agents adverse effects
Biomarkers blood
Cardiovascular Diseases diagnosis
Cardiovascular Diseases etiology
Clinical Trials as Topic
Down-Regulation
Drug Therapy, Combination
Evidence-Based Medicine
Ezetimibe adverse effects
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects
Hypercholesterolemia blood
Hypercholesterolemia complications
Hypercholesterolemia diagnosis
Practice Guidelines as Topic
Risk Assessment
Risk Factors
Treatment Outcome
Anticholesteremic Agents therapeutic use
Cardiovascular Diseases prevention & control
Cholesterol blood
Ezetimibe therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
Hypercholesterolemia drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1484
- Volume :
- 240
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Atherosclerosis
- Publication Type :
- Academic Journal
- Accession number :
- 25795557
- Full Text :
- https://doi.org/10.1016/j.atherosclerosis.2015.03.002